Assessing Disease Severity in Late Infantile Neuronal Ceroid Lipofuscinosis Using Quantitative MR Diffusion-Weighted Imaging

References

1. ↵
   Crystal RG, Sondhi D, Hackett NR, et al. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis. Hum Gene Ther 2004;15:1131–54

   PubMedWeb of Science
2. ↵
   Autti T, Raininko R, Santavuori P, et al. MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type. Neuroradiology 1997;39:371–77

   CrossRefPubMedWeb of Science
3. ↵
   Sondhi D, Hackett NR, Apblett RL, et al. Feasibility of gene therapy for late neuronal ceroid lipofuscinosis. Arch Neurol 2001;58:1793–98

   CrossRefPubMed
4. ↵
   Steinfeld R, Heim P, von Gregory H, et al. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet 2002;112:347–54

   CrossRefPubMedWeb of Science
5. ↵
   Ballon D, Dyke J, Schwartz LH, et al. Imaging therapeutic response in human bone marrow using rapid whole-body MRI. NMR Biomed 2000;13:321–28

   CrossRefPubMed
6. Bosma GP, Huizinga TW, Mooijaart SP, et al. Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol 2003;24:850–54

   Abstract/FREE Full Text
7. ↵
   Kantarci K. Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease. Expert Rev Neurotherapy 2005;5:663–70

   CrossRef
8. ↵
   Ulug AM. Monitoring brain development with quantitative diffusion tensor imaging. Develop Science 2002;5:286–92

   CrossRef
9. ↵
   Mukherjee P, McKinstry RC. Diffusion tensor imaging and tractography of human brain development. Neuroimaging Clin N Am 2006;16:19–43

   CrossRefPubMedWeb of Science
10. ↵
    Laidlaw DH, Fleischer KW, Barr AH. Partial-volume Bayesian classification of material mixtures in MR volume data using voxel histograms. IEEE Trans Med Imag 1998;17:74–86

    CrossRefPubMed
11. ↵
    Chun T, Filippi CG, Zimmerman RD, et al. Diffusion changes in the aging human brain. AJNR Am J Neuroradiol 2000;21:1078–83

    Abstract/FREE Full Text
12. ↵
    Hedges S, Shah P. Comparison of mode estimation methods and application in molecular clock analysis. BMC Bioinformatics 2003;4:31

    CrossRefPubMed
13. ↵
    Nardocci N, Verga ML, Binelli S, et al. Neuronal ceroid-lipofuscinosis: a clinical and morphological study of 19 patients. Am J Med Genet 1995;57:137–41

    CrossRefPubMed
14. Santavuori P, Vanhanen SL, Autti T. Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders. Eur J Paediatr Neurol 2001;5:157–61

    CrossRefPubMed
15. Vanhanen SL, Puranen J, Autti T, et al. Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease. Neuropediatrics 2004;35:27–35

    CrossRefPubMedWeb of Science
16. ↵
    Lagenstein I, Schwendemann G, Kuhne D, et al. Neuronal ceroidlipofuscinosis: CCT findings in fourteen patients. Acta Paediatr Scand 1981;70:857–60

    PubMedWeb of Science
17. ↵
    Seppi K, Schocke MF. An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative Parkinsonism. Curr Opin Neurol 2005;18:370–75

    PubMedWeb of Science
18. ↵
    Seitz D, Grodd W, Schwab A, et al. MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis. AJNR Am J Neuroradiol 1998;19:1373–77

    Abstract
19. ↵
    Shungu DC, Worgall S, Mao X, et al. Spectral characteristics of late infantile neuronal ceroid lipofuscinosis (“Batten disease”) investigated in vivo by 1H magnetic resonance spectroscopic imaging at 3.0 T. Proc Int Soc Magnet Res Med 2005;13:1268
20. ↵
    Mascalchi M, Moretti M, Della Nave R, et al. Longitudinal evaluation of leukoaraiosis with whole brain ADC histograms. Neurology 2002;59:938–40

    Abstract/FREE Full Text
21. ↵
    Wilson M, Morgan PS, Lin X, et al. Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:318–22

    Abstract/FREE Full Text
22. ↵
    Mascalchi M, Lolli F, Della Nave R, et al. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 2004;232:867–73

    CrossRefPubMedWeb of Science
23. ↵
    Steens SC, Admiraal-Behloul F, Schaap JA, et al. Reproducibility of brain ADC histograms. Eur Radiol 2004;14:425–30

    CrossRefPubMed
24. ↵
    Hachiya Y, Hayashi M, Kumada S, et al. Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses. Acta Neuropathol (Berl) 2006;111:168–77

    CrossRefPubMed